Description:
An immunomodulator consisting of inactivated (killed) parapox ovis virus Zylexis aids in the reduction of upper respiratory disease associated with EHV-1 and EHV-4 that can be expensive to treat and may compromise the health of other horses resulting in lost training or competition time.

Advantages:Equine herpesvirus (EHV) types 1 4 latently infects 80% of all horses.
EHV-1 has been demonstrated to cause respiratory disease including pneumonia abortion and stillbirth in pregnant mares and neurologic symptoms.
EHV-4 has been demonstrated to cause respiratory disease in young and stressed horses.
Equine herpesvirus is easily reactivated by common stressors such as environmental changes training competition and trailering.
Reactivation causes a high viral load that can contribute to sickness respiratory signs and sometimes results in pneumonia.
These infections can be expensive to treat may compromise the health of other horses in the barn and may result in lost training/competition time for valuable show horses.
Safe for use in healthy horses including foals four months of age and older.